Evidence map›Paper›PMID 31915391›Full record

ArticleNature protocols2020

A toolbox for the longitudinal assessment of healthspan in aging mice.

I Bellantuono, R de Cabo, D Ehninger, C Di Germanio, A Lawrie, J Miller, S J Mitchell, I Navas-Enamorado, P K Potter, T Tchkonia and 2 more

Abstract read
In one paragraph

Article in Nature protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

I BellantuonoDepartment of Oncology and Metabolism, Healthy Lifespan Institute and MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing, University of Sheffield, Sheffield, UK. i.bellantuono@shef.ac.uk.ORCID http://orcid.org/0000-0001-9994-6987
R de CaboTranslational Gerontology Branch, National Institutes of Health, Baltimore, MD, USA.
D EhningerGerman Center for Neurodegenerative Diseases (DZNE), Venusberg Campus 1, Bonn, Germany.
C Di GermanioTranslational Gerontology Branch, National Institutes of Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-6047-211X
A LawrieDepartment of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-4192-9505
J MillerRobert and Arlene KogodCenter on Aging, Mayo Clinic, Rochester, MN, USA.
S J MitchellDepartment of Molecular Medicine, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
I Navas-EnamoradoTranslational Gerontology Branch, National Institutes of Health, Baltimore, MD, USA.
P K PotterDepartment of Biological and Life Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxfordshire, UK.
T TchkoniaRobert and Arlene KogodCenter on Aging, Mayo Clinic, Rochester, MN, USA.
J L TrejoDepartment of Translational Neuroscience, Cajal Institute (CSIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-0618-5547
D W LammingWilliam S. Middleton Memorial Veterans Hospital, Madison, WI, USA. dlamming@medicine.wisc.edu.ORCID http://orcid.org/0000-0002-0079-4467

Funding

Aging Intervention ProgramZIAAG000363 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2009 to 2025
$9.0M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
Study of Longitudinal Aging in MiceZIAAG000335 · NIA · NATIONAL INSTITUTE ON AGING · PI DE CABO, RAFAEL · 2017 to 2025
$5.0M
Effect of Aging on Preadipocyte DifferentiationR01AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 1997 to 2012
$3.7M
The regulation of health and longevity by branched-chain amino acidsR01AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Dudley William Lamming · 2018 to 2026
$3.1M
The regulation of health and longevity by branched-chain amino acidsRF1AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2023 to 2023
$2.1M
Comparative analysis of geroprotective interventions in established and novel mouse models of Alzheimer's diseaseR01AG062328 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM, MERRINS, MATTHEW J. · 2018 to 2022
$2.0M
The regulation of health and longevity by branched-chain amino acidsR56AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2017 to 2017
$573k
Intervention in Progeria by Alterations in dietary macronutrient CompositionR21AG051974 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2017 to 2018
$409k
Promoting metabolic health through the reduction of dietary branched chain amino acidsI01BX004031 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI LAMMING, DUDLEY WILLIAM · 2018 to 2022
–
BLRD VA I01 BX004031British Heart Foundation FS/18/52/33808Medical Research Council MR/P020941/1NIA NIH HHS R01 AG013925NIA NIH HHS R01 AG056771NIA NIH HHS R01 AG062328NIA NIH HHS R21 AG051974NIA NIH HHS R37 AG013925NIA NIH HHS R56 AG056771NIA NIH HHS RF1 AG056771
6 · The paper itself

Abstract

The number of people aged over 65 is expected to double in the next 30 years. For many, living longer will mean spending more years with the burdens of chronic diseases such as Alzheimer's disease, cardiovascular disease, and diabetes. Although researchers have made rapid progress in developing geroprotective interventions that target mechanisms of aging and delay or prevent the onset of multiple concurrent age-related diseases, a lack of standardized techniques to assess healthspan in preclinical murine studies has resulted in reduced reproducibility and slow progress. To overcome this, major centers in Europe and the United States skilled in healthspan analysis came together to agree on a toolbox of techniques that can be used to consistently assess the healthspan of mice. Here, we describe the agreed toolbox, which contains protocols for echocardiography, novel object recognition, grip strength, rotarod, glucose tolerance test (GTT) and insulin tolerance test (ITT), body composition, and energy expenditure. The protocols can be performed longitudinally in the same mouse over a period of 4-6 weeks to test how candidate geroprotectors affect cardiac, cognitive, neuromuscular, and metabolic health.

Indexed as

HealthAgingAnimalsBody CompositionElectrocardiographyEnergy MetabolismGlucose Tolerance TestHand StrengthInsulin ResistanceLongitudinal StudiesMiceMice, Inbred C57BLRecognition, Psychology

Identifiers

PMID31915391
PMCPMC7002283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.